Michael Holston - Merck Insider

Executive Vice President Chief Ethics and Compliance Officer

Mr. Michael J. Holston is Executive Vice President, General Counsel of Merck Co Inc. with effect from July 1, 2015
Age: 52  President Since 2015      
908 735-1500  www.merck.com
Michael Holston EducationHolston most recently served as executive vice president and general counsel for HewlettPackard Company, where he oversaw compliance, government affairs, privacy, ethics operations and legal affairs. Prior to his role with HewlettPackard, Holston was a partner in the litigation practice at Morgan, Lewis & Bockius LLP, where he served as external counsel to Merck on matters such as product litigation, government investigations and compliance with healthcare laws and regulations. Before joining Morgan Lewis, he served as a prosecutor in the criminal division of the U.S. Attorney Office for the Eastern District of Pennsylvania. Holston received his J.D. from Villanova University School of Law, Villanova, Penn. and a B.S.M.E. from the University of Notre Dame, South Bend, Indiana. He also is a fellow in the American College of Trial Lawyers.

Management Efficiency

The company has Return on Asset of 6.58 % which means that on every $100 spent on asset it made $6.58 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 10.4 % implying that it generated $10.4 on every 100 dollars invested.
The company has 28.51 B in debt with debt to equity (D/E) ratio of 71.1 . This implies that the company may be unable to create cash to meet all of its financial commitments. Merck Co Inc has Current Ratio of 1.56 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

Murthy SimhambhatlaAbbott Laboratories
2013
Thomas FrinziAbbott Laboratories
2016
Jonathon KellermanAllergan plc
2014
Ronald HuttonBio Rad Laboratories Inc
2012
Roger BirdAbbott Laboratories
2015
Matthew MalettaEndo International plc
2015
Charles FoltzAbbott Laboratories
2013
Robert FordAbbott Laboratories
2015
Shannon HallBio Rad Laboratories Inc
2014
Camille FarhatEndo International plc
2012
Paul SilvaVertex Pharmaceuticals Incorpor
2011
Brian LortieEndo International plc
N/A
William MeuryAllergan plc
2015
Jared WatkinAbbott Laboratories
2015
Blaise ColemanEndo International plc
2016
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Michael PariniVertex Pharmaceuticals Incorpor
2017
Robert FunckAbbott Laboratories
2013
Deepak NathAbbott Laboratories
2015
J WhiteAbbott Laboratories
2013
Ian SmithVertex Pharmaceuticals Incorpor
2017

Entity Summary

Merck & Co., Inc. offer healthcare solutions worldwide. Merck Co Inc (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 66,645 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run CEO Directory Now
   

CEO Directory

Screen CEOs from public companies around the world
Hide  View All  Next  Launch CEO Directory
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Merck Co Inc to your portfolio

Top Management

Merck Co Inc Leadership Team
Thomas Glocer, Director
C Kidder, Director
Craig Thompson, Director
Rochelle Lazarus, Director
Michael Rosenblatt, President, Ph.D
Wendell Weeks, Director
Michael Holston, President
Paul Rothman, Director
Adele Ambrose, President
Joseph Romanelli, Executive
Mirian GraddickWeir, President, Ph.D
Peter Wendell, Director
Leslie Brun, Director
Julie Gerberding, President
Pamela Craig, Director, MBA
Patricia Russo, Director
Willie Deese, President
Rita Karachun, SVP
Robert Davis, CFO
Robert Kidder, Director
Thomas Cech, Director, Ph.D
Clark Golestani, EVP
William Harrison, Director
Bruce Kuhlik, EVP
Roger Perlmutter, President, Ph.D
Sanat Chattopadhyay, President
Adam Schechter, President
Carlos Represas, Director
Richard DeLuca, President
Kenneth Frazier, Chairman

Stock Performance

Merck Performance Indicators